New York State Common Retirement Fund’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$599K Buy
6,326
+2,854
+82% +$286K ﹤0.01% 1931
2026
Q1
$233K Hold
3,472
﹤0.01% 2173
2025
Q4
$274K Hold
3,472
﹤0.01% 2168
2025
Q3
$117K Hold
3,472
﹤0.01% 2549
2025
Q2
$49.5K Hold
3,472
﹤0.01% 2945
2025
Q1
$48.6K Hold
3,472
﹤0.01% 2787
2024
Q4
$53.5K Hold
3,472
﹤0.01% 2838
2024
Q3
$54.4K Sell
3,472
-1
-0% -$14 ﹤0.01% 2833
2024
Q2
$49.2K Buy
+3,473
New +$54.3K ﹤0.01% 3090

Other funds holding INBX

New York State Common Retirement Fund's INBX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Inhibrx (INBX) stake by 82% in Q2 2026, buying an estimated $286K and bringing the position to 6,326 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

New York State Common Retirement Fund first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 32 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • New York State Common Retirement Fund held 6,326 shares of Inhibrx worth $599K as of Q2 2026.
  • New York State Common Retirement Fund bought 2,854 Inhibrx shares in Q2 2026, an estimated $286K.
  • Inhibrx made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1931 holding.
  • New York State Common Retirement Fund first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 32 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.